by In2Pharma | Jul 11, 2025 | News
Belgium The Belgian FAQ on nutrition and health claims has been updated (June 2025 version). Several key questions have been revised or expanded. Notable updates include: Definition of a health claim (Q3): The term now explicitly includes statements that indicate the...
by In2Pharma | Jul 9, 2025 | News
The Netherlands Currently, numerous variations of the phrase ‘read the leaflet before use’ appear on promotional materials for health products. To improve clarity and consistency, the Dutch Knowledge and Advice Centre (KOAG KAG) now proposes a more uniform approach to...
by In2Pharma | Jul 3, 2025 | News
Europe As of October 17, 2023, the EU’s new microplastics restriction under the REACH regulation has officially entered into force (Commission Regulation (EU) 2023/2055). This restriction bans the sale of products containing intentionally added microplastics,...
by In2Pharma | Jul 1, 2025 | News
The Netherlands GMP-certificates are issued by the Healthcare and Youth Inspectorate (IGJ) to manufacturers in the Netherlands when they comply with Good Manufacturing Practice (GMP). Currently, GMP-certificate holders can submit a request for a new or adapted...
by In2Pharma | Jul 1, 2025 | News
Belgium Starting 1 June 2025, the Federal Agency for Medicines and Health Products (FAMHP) will require companies to use a new contact form for inquiries regarding variations and renewals of marketing authorisations for human medicinal products. This form will replace...
by In2Pharma | Jun 11, 2025 | News
Belgium The FAMHP published a section listing medical devices and in vitro diagnostic medical devices notified under Article 10bis of regulations (EU) 2017/745 and 2017/746, introduced by the regulation (EU) 2024/1860. The list includes medical devices that are...
